Contraceptives Market (Product: Contraceptive Drugs [Oral Contraceptives, Contraceptive Injectable, and Topical Contraceptive Patch] and Contraceptive Devices [Male Contraceptive Devices and Female Contraceptive Devices]; and Distribution Channel: Hospitals Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Description

Contraceptives Market Outlook 2028

The global contraceptives market was valued at US$ 893.9 Mn in 2020

It is estimated to expand at a CAGR of 15.5% from 2021 to 2028

The global contraceptives market is expected to cross the value of US$ 2.7 Bn by the end of 2028

Analysts’ Viewpoint on Contraceptives Market Scenario

Birth spacing methods amid the ongoing COVID-19 pandemic include precise advice on lactation amenorrhoea method (LAM) to enhance its efficacy, barrier methods such as condoms, and plentiful supplies of oral progestin-only pill, among others. The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players. Since there is a lack of awareness about the advantages of contraceptives in developing economies, market stakeholders should initiate collaborative agreements with governments to educate women as well as related individuals about different alternatives. Manufacturers should increase the production of affordable contraceptive options to boost their uptake in developing economies.

High Prevalence of Sexually Transmitted Infections Propels Demand for Contraceptives

A number of international and national organizations have initiated STI (sexually transmitted infections) awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.

Increase in adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptives market. People across the world have become more aware about the need of family planning.

Birth Spacing Helps Reduce Burden on Healthcare Systems amid COVID-19 Pandemic

The COVID-19 pandemic has heightened the importance for family planning since most people have been spending time indoors. Manufacturers in the contraceptives market are capitalizing on this opportunity to ensure uninterrupted supply of oral contraceptives, contraceptive injectables, and contraceptive devices. Healthcare organizations are stressing on the advantages of birth spacing during the ongoing pandemic, since avoiding pregnancy during such uncertain times is wise for women not only on a personal level but also from a public health perspective in terms of not adding to overburdened healthcare systems. Manufacturers are increasing efforts to prevent stock-outs for implants, oral contraceptive pills, and copper intrauterine devices.

Comprehensive Product Portfolio Allows Stakeholders to Expand Income Sources

The contraceptives market is likely to provide new vendors significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the market.

Oral (pill) contraceptives, topical contraceptives, and injectable contraceptives are various types of contraceptives. Contraceptive devices, on the other hand, include condoms, intrauterine devices (IUD), vaginal rings, implants, patches, diaphragms, sponges, etc. The barrier method, particularly condoms, is the most common form of artificial contraception.

The global contraceptives market is expected to be driven by increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies.

Lack of Knowledge about Advantages of Contraceptives Hampers Market Growth

Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average. In Asia, majority of unintended pregnancies is caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion.

Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in this market. Hence, participants in the market should collaborate with governments to increase awareness about the advantages of contraceptives, which holds potential to boost product sales.

U.S. Sets Benchmark for Contraceptive Innovation and Collaborative Agreements

Key players in the global contraceptives market are engaged in regulatory approvals, innovations in technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptives market. A few expansion strategies adopted by players operating in the global contraceptives market are announcing the generic versions of vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptives market.

Healthcare organizations are launching global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market. At the same time, manufacturers are investing in R&D to increase availability of FDA (Food and Drug Administration)-approved contraceptive options.

Contraceptives Market: Overview

According to Transparency Market Research’s latest report on the global contraceptives market for the historical period 2017–2018 and forecast period 2019–2027, decline in prices and increase in access to contraceptives are projected to drive the global contraceptives market during the forecast period

Rise in Prevalence of Sexually Transmitted Diseases Drives Demand for Contraceptive Tablets and Other Forms of Contraception

A number of international and national organizations have initiated STI awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.

Increase in adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptives market. People across the world have become more aware about the need of family planning.

Entry of New Vendors with Advanced Contraceptive Methods: Key Driver

The global contraceptives market is likely to provide new vendors significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the global contraceptives market.

Lack of Awareness about Application of Contraceptive Devices in Emerging Countries

Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average.

In Asia, majority of unintended pregnancies are caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion

Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in the global contraceptives market.

Competition Landscape

This report profiles major players in the global contraceptives market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players

Leading players operating in the global contraceptives market are

  • Merck & Co., Inc., Cipla, Inc.
  • Allergan plc
  • Bayer AG
  • HLL Lifecare Limited
  • Mankind Pharma
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mithra Pharmaceuticals
  • Janssen Pharmaceutical Company
  • Reckitt Benckiser Group plc., etc.

Key Developments

Key players in the global contraceptives market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptives market. A few expansion strategies adopted by players operating in the global contraceptives market are:

On January 14, 2021, Teva Pharmaceuticals announced the generic version of NuvaRing (etonogestrel and ethinyl estradiol) vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptives market.

On November 17, 2020, the World Health Organization launched global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market.

On May 22, 2020, Evofem Biosciences, Inc. announced that the U.S. Food and Drug Administration had approved Phexxi, a new contraceptive method

The report on the global contraceptives market discussed individual strategies, followed by company profiles of manufacturers of contraceptives devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global contraceptives market.

Key Questions Answered in Contraceptives Market Report

  • What is the scope of growth of product companies in the global contraceptives market?
  • What will be the Y-o-Y growth of the global contraceptives market between 2017 and 2028?
  • What is the influence of changing trends in technologies on the global contraceptives market?
  • Will North America to be the most profitable market for contraceptives devices providers?
  • Which factors are anticipated to hamper the growth of the global contraceptives market during the forecast period?
  • Which are the leading companies in the global contraceptives market?

Contraceptives Market – Segmentation

Product

  • Contraceptive Drugs
  • Oral Contraceptives
  • Combined Contraceptives
  • Mini-pills
  • Contraceptive Injectable
  • Topical Contraceptive Patch
  • Contraceptive Devices
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Tissue Engineering

Distribution Channel

  • Hospitals Pharmacy
  • Public
  • Private
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

 

1. Preface

 

    1.1. Market Definition and Scope

 

    1.2. Market Segmentation

 

    1.3. Key Research Objectives

 

    1.4. Research Highlights

 

2. Assumptions and Research Methodology

 

3. Executive Summary: Global Contraceptives Market

 

4. Market Overview

 

    4.1. Introduction

 

    4.2. Overview

 

    4.3. Key Market Indicators

 

    4.4. Market Dynamics

 

        4.4.1. Drivers

 

        4.4.2. Restraints

 

        4.4.3. Opportunity

 

    4.5. Global Contraceptives Market Analysis and Forecast, 2017–2028

 

        4.5.1. Market Revenue Projections (US$ Mn)

 

    4.6. Global Contraceptives Market - Global Supply Demand Scenario

 

    4.7. Porter’s Five Force Analysis

 

    4.8. Value Chain Analysis

 

    4.9. Market Outlook

 

5. Global Contraceptives Market Analysis and Forecast, By Product

 

    5.1. Introduction & Definition

 

    5.2. Key Findings / Developments

 

    5.3. Key Trends

 

    5.4. Market Value Forecast, by Product, 2017–2028

 

        5.4.1. Contraceptives Drugs

 

            5.4.1.1. Oral Contraceptives

 

                5.4.1.1.1. Combined Contraceptives

 

                5.4.1.1.2. Mini-pills

 

            5.4.1.2. Contraceptive Injectable

 

            5.4.1.3. Topical Contraceptive Patch

 

        5.4.2. Contraceptive Devices

 

            5.4.2.1. Male Contraceptive Devices

 

            5.4.2.2. Female Contraceptive Devices

 

                5.4.2.2.1. Female Condoms

 

                5.4.2.2.2. Contraceptive Diaphragms

 

                5.4.2.2.3. Contraceptive Sponges

 

                5.4.2.2.4. Contraceptive Vaginal Rings

 

                5.4.2.2.5. Intrauterine Devices

 

                5.4.2.2.6. Sub-dermal Contraceptives Implants

 

                5.4.2.2.7. Non-Surgical Permanent Contraception Devices

 

    5.5. Market Attractiveness Analysis, By Product

 

6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel

 

    6.1. Introduction & Definition

 

    6.2. Key Findings / Developments

 

    6.3. Key Trends

 

    6.4. Market Value Forecast, by Distribution Channel, 2017–2028

 

        6.4.1. Hospital Pharmacy

 

            6.4.1.1. Public

 

            6.4.1.2. Private

 

        6.4.2. Independent Pharmacy

 

        6.4.3. Online Platform

 

        6.4.4. Clinics

 

        6.4.5. Others

 

    6.5. Market Attractiveness Analysis, By Distribution Channel

 

7. Global Contraceptives Market Analysis and Forecast, By Region

 

    7.1. Key Findings

 

    7.2. Policies and Regulations

 

    7.3. Market Value Forecast, by Region

 

        7.3.1. North America

 

        7.3.2. Europe

 

        7.3.3. Asia Pacific

 

        7.3.4. Latin America

 

        7.3.5. Middle East and Africa

 

    7.4. Market Attractiveness Analysis, By Country/Region

 

8. North America Contraceptives Market Analysis and Forecast

 

    8.1. Introduction

 

        8.1.1. Key Findings

 

        8.1.2. Policies and Regulations

 

        8.1.3. Key Trends

 

    8.2. Market Value Forecast, by Product, 2017–2028

 

        8.2.1. Contraceptive Drugs

 

            8.2.1.1. Oral Contraceptives

 

                8.2.1.1.1. Combined Contraceptives

 

                8.2.1.1.2. Mini-pills

 

            8.2.1.2. Contraceptive Injectable

 

            8.2.1.3. Topical Contraceptive Patch

 

        8.2.2. Contraceptive Devices

 

            8.2.2.1. Male Contraceptive Devices

 

            8.2.2.2. Female Contraceptive Devices

 

                8.2.2.2.1. Female Condoms

 

                8.2.2.2.2. Contraceptive Diaphragms

 

                8.2.2.2.3. Contraceptive Sponges

 

                8.2.2.2.4. Contraceptive Vaginal Rings

 

                8.2.2.2.5. Intrauterine Devices

 

                8.2.2.2.6. Sub-dermal Contraceptives Implants

 

                8.2.2.2.7. Non-Surgical Permanent Contraception Devices

 

    8.3. Market Value Forecast, by Distribution Channel, 2017–2028

 

        8.3.1. Hospital Pharmacy

 

            8.3.1.1. Public

 

            8.3.1.2. Private

 

        8.3.2. Independent Pharmacy

 

        8.3.3. Online Platform

 

        8.3.4. Clinics

 

        8.3.5. Others

 

    8.4. Market Value Forecast, by Country, 2017–2028

 

        8.4.1. U.S.

 

        8.4.2. Canada

 

    8.5. Market Attractiveness Analysis

 

        8.5.1. By Product

 

        8.5.2. By Distribution Channel

 

        8.5.3. By Country

 

9. Europe Contraceptives Market Analysis and Forecast

 

    9.1. Introduction

 

        9.1.1. Key Findings

 

        9.1.2. Policies and Regulations

 

        9.1.3. Key Trends

 

    9.2. Market Value Forecast, by Product, 2017–2028

 

        9.2.1. Contraceptive Drugs

 

            9.2.1.1. Oral Contraceptives

 

                9.2.1.1.1. Combined Contraceptives

 

                9.2.1.1.2. Mini-pills

 

            9.2.1.2. Contraceptive Injectable

 

            9.2.1.3. Topical Contraceptive Patch

 

        9.2.2. Contraceptive Devices

 

            9.2.2.1. Male Contraceptive Devices

 

            9.2.2.2. Female Contraceptive Devices

 

                9.2.2.2.1. Female Condoms

 

                9.2.2.2.2. Contraceptive Diaphragms

 

                9.2.2.2.3. Contraceptive Sponges

 

                9.2.2.2.4. Contraceptive Vaginal Rings

 

                9.2.2.2.5. Intrauterine Devices

 

                9.2.2.2.6. Sub-dermal Contraceptives Implants

 

                9.2.2.2.7. Non-Surgical Permanent Contraception Devices

 

    9.3. Market Value Forecast, by Distribution Channel, 2017–2028

 

        9.3.1. Hospital Pharmacy

 

            9.3.1.1. Public

 

            9.3.1.2. Private

 

        9.3.2. Independent Pharmacy

 

        9.3.3. Online Platform

 

        9.3.4. Clinics

 

        9.3.5. Others

 

    9.4. Market Value Forecast, by Country/Sub-region, 2017–2028

 

        9.4.1. Germany

 

        9.4.2. France

 

        9.4.3. U.K.

 

        9.4.4. Spain

 

        9.4.5. Italy

 

        9.4.6. Russia

 

        9.4.7. Rest of Europe

 

    9.5. Market Attractiveness Analysis

 

        9.5.1. By Product

 

        9.5.2. By Distribution Channel

 

        9.5.3. By Country/Sub-region

 

10. Asia Pacific Contraceptives Market Analysis and Forecast

 

    10.1. Introduction

 

        10.1.1. Key Findings

 

        10.1.2. Policies and Regulations

 

        10.1.3. Key Trends

 

    10.2. Market Value Forecast, by Product, 2017–2028

 

        10.2.1. Contraceptive Drugs

 

            10.2.1.1. Oral Contraceptives

 

                10.2.1.1.1. Combined Contraceptives

 

                10.2.1.1.2. Mini-pills

 

            10.2.1.2. Contraceptive Injectable

 

            10.2.1.3. Topical Contraceptive Patch

 

        10.2.2. Contraceptive Devices

 

            10.2.2.1. Male Contraceptive Devices

 

            10.2.2.2. Female Contraceptive Devices

 

                10.2.2.2.1. Female Condoms

 

                10.2.2.2.2. Contraceptive Diaphragms

 

                10.2.2.2.3. Contraceptive Sponges

 

                10.2.2.2.4. Contraceptive Vaginal Rings

 

                10.2.2.2.5. Intrauterine Devices

 

                10.2.2.2.6. Sub-dermal Contraceptives Implants

 

                10.2.2.2.7. Non-Surgical Permanent Contraception Devices

 

    10.3. Market Value Forecast, by Distribution Channel, 2017–2028

 

        10.3.1. Hospital Pharmacy

 

            10.3.1.1. Public

 

            10.3.1.2. Private

 

        10.3.2. Independent Pharmacy

 

        10.3.3. Online Platforms

 

        10.3.4. Clinics

 

        10.3.5. Others

 

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2028

 

        10.4.1. China

 

        10.4.2. Japan

 

        10.4.3. India

 

        10.4.4. Australia & New Zealand

 

        10.4.5. Rest of Asia Pacific

 

    10.5. Market Attractiveness Analysis

 

        10.5.1. By Product

 

        10.5.2. By Distribution Channel

 

        10.5.3. By Country/Sub-region

 

11. Latin America Contraceptives Market Analysis and Forecast

 

    11.1. Introduction

 

        11.1.1. Key Findings

 

        11.1.2. Policies and Regulations

 

        11.1.3. Key Trends

 

    11.2. Market Value Forecast, by Product, 2017–2028

 

        11.2.1. Contraceptive Drugs

 

            11.2.1.1. Oral Contraceptives

 

                11.2.1.1.1. Combined Contraceptives

 

                11.2.1.1.2. Mini-pills

 

            11.2.1.2. Contraceptive Injectable

 

            11.2.1.3. Topical Contraceptive Patch

 

        11.2.2. Contraceptive Devices

 

            11.2.2.1. Male Contraceptive Devices

 

            11.2.2.2. Female Contraceptive Devices

 

                11.2.2.2.1. Female Condoms

 

                11.2.2.2.2. Contraceptive Diaphragms

 

                11.2.2.2.3. Contraceptive Sponges

 

                11.2.2.2.4. Contraceptive Vaginal Rings

 

                11.2.2.2.5. Intrauterine Devices

 

                11.2.2.2.6. Sub-dermal Contraceptives Implants

 

                11.2.2.2.7. Non-Surgical Permanent Contraception Devices

 

    11.3. Market Value Forecast, by Distribution Channel, 2017–2028

 

        11.3.1. Hospital Pharmacy

 

            11.3.1.1. Public

 

            11.3.1.2. Private

 

        11.3.2. Independent Pharmacy

 

        11.3.3. Online Platforms

 

        11.3.4. Clinics

 

        11.3.5. Others

 

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2028

 

        11.4.1. Brazil

 

        11.4.2. Mexico

 

        11.4.3. Rest of Latin America

 

    11.5. Market Attractiveness Analysis

 

        11.5.1. By Product

 

        11.5.2. By Distribution Channel

 

        11.5.3. By Country/Sub-region

 

12. Middle East and Africa Contraceptives Market Analysis and Forecast

 

    12.1. Introduction

 

        12.1.1. Key Findings

 

        12.1.2. Policies and Regulations

 

        12.1.3. Key Trends

 

    12.2. Market Value Forecast, by Product, 2017–2028

 

        12.2.1. Contraceptive Drugs

 

            12.2.1.1. Oral Contraceptives

 

                12.2.1.1.1. Combined Contraceptives

 

                12.2.1.1.2. Mini-pills

 

            12.2.1.2. Contraceptive Injectable

 

            12.2.1.3. Topical Contraceptive Patch

 

        12.2.2. Contraceptive Devices

 

            12.2.2.1. Male Contraceptive Devices

 

            12.2.2.2. Female Contraceptive Devices

 

                12.2.2.2.1. Female Condoms

 

                12.2.2.2.2. Contraceptive Diaphragms

 

                12.2.2.2.3. Contraceptive Sponges

 

                12.2.2.2.4. Contraceptive Vaginal Rings

 

                12.2.2.2.5. Intrauterine Devices

 

                12.2.2.2.6. Sub-dermal Contraceptives Implants

 

                12.2.2.2.7. Non-Surgical Permanent Contraception Devices

 

    12.3. Market Value Forecast, by End User, 2017–2028

 

        12.3.1. Hospital Pharmacy

 

            12.3.1.1. Public

 

            12.3.1.2. Private

 

        12.3.2. Independent Pharmacy

 

        12.3.3. Online Platform

 

        12.3.4. Clinics

 

        12.3.5. Others

 

    12.4. Market Value Forecast, by Country /Sub-region, 2017–2028

 

        12.4.1. GCC Countries

 

        12.4.2. South Africa

 

        12.4.3. Rest of Middle East and Africa

 

    12.5. Market Attractiveness Analysis

 

        12.5.1. By Product

 

        12.5.2. By Distribution Channel

 

        12.5.3. By Country/Sub-region

 

13. Competition Landscape

 

    13.1. Market Player - Competition Matrix (by tier and size of companies)

 

    13.2. Market Share Analysis, by Company, 2020

 

    13.3. Company Profiles

 

        13.3.1. Merck & Co., Inc.

 

            13.3.1.1. Overview

 

            13.3.1.2. Financials

 

            13.3.1.3. Recent Developments

 

            13.3.1.4. Strategy

 

        13.3.2. Cipla, Inc.

 

            13.3.2.1. Overview

 

            13.3.2.2. Financials

 

            13.3.2.3. Recent Developments

 

            13.3.2.4. Strategy

 

        13.3.3. Allergan plc

 

            13.3.3.1. Overview

 

            13.3.3.2. Financials

 

            13.3.3.3. Recent Developments

 

            13.3.3.4. Strategy

 

        13.3.4. Bayer AG

 

            13.3.4.1. Overview

 

            13.3.4.2. Financials

 

            13.3.4.3. Recent Developments

 

            13.3.4.4. Strategy

 

        13.3.5. HLL Lifecare Limited

 

            13.3.5.1. Overview

 

            13.3.5.2. Financials

 

            13.3.5.3. Recent Developments

 

            13.3.5.4. Strategy

 

        13.3.6. Mankind Pharma

 

            13.3.6.1. Overview

 

            13.3.6.2. Financials

 

            13.3.6.3. Recent Developments

 

            13.3.6.4. Strategy

 

        13.3.7. Pfizer, Inc.

 

            13.3.7.1. Overview

 

            13.3.7.2. Financials

 

            13.3.7.3. Recent Developments

 

            13.3.7.4. Strategy

 

        13.3.8. Teva Pharmaceutical Industries Ltd.

 

            13.3.8.1. Overview

 

            13.3.8.2. Financials

 

            13.3.8.3. Recent Developments

 

            13.3.8.4. Strategy

 

        13.3.9. Mithra Pharmaceuticals

 

            13.3.9.1. Overview

 

            13.3.9.2. Financials

 

            13.3.9.3. Recent Developments

 

            13.3.9.4. Strategy

 

        13.3.10. Janssen Pharmaceutical Company

 

            13.3.10.1. Overview

 

            13.3.10.2. Financials

 

            13.3.10.3. Recent Developments

 

            13.3.10.4. Strategy

 

        13.3.11. Reckitt Benckiser Group plc

 

            13.3.11.1. Overview

 

            13.3.11.2. Financials

 

            13.3.11.3. Recent Developments

 

            13.3.11.4. Strategy

 

 

Choose License Type

Checkout Inquiry Sample